These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30581483)

  • 1. Normative Application of Xiyanping Injection: A Systematic Review of Adverse Case Reports.
    Chen S; Kwong JSW; Zheng R; Wang Y; Shang H
    Evid Based Complement Alternat Med; 2018; 2018():4013912. PubMed ID: 30581483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with the severity of adverse drug reactions by Xiyanping injection: A propensity score-matched analysis.
    Zheng R; Tao L; Kwong JSW; Zhong C; Li C; Chen S; Sun Y; Zhang X; Shang H
    J Ethnopharmacol; 2020 Mar; 250():112424. PubMed ID: 31765765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of adverse events associated with Xiyanping-Ribavirin combination: A systematic review.
    Zheng R; Sun Y; Zhang X; Zhao C; Wang P; Chen S; Chen Z; Qiu R; Liang A; Shang H
    J Ethnopharmacol; 2022 Jun; 292():115076. PubMed ID: 35227782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic review of medication safety of Xiyanping injection in conformity with indications of package inserts].
    Chen YY; Xie YM; Liao X; Chen HY
    Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(18):3463-3472. PubMed ID: 28925133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with
    Li Q; Li ZY; Zhang J; Guo WN; Xu XM; Sun FX; Xu H
    Evid Based Complement Alternat Med; 2019; 2019():2346583. PubMed ID: 31558910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable importance for projection (VIP) scores for analyzing the contribution of risk factors in severe adverse events to Xiyanping injection.
    Zheng R; Chen Z; Guan Z; Zhao C; Cui H; Shang H
    Chin Med; 2023 Feb; 18(1):15. PubMed ID: 36782216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Medication Use With Xiyanping Injection and the Risk of Suspected Allergic Reactions: A Nested Case-Control Study Based on China's National Medical Insurance Database.
    Tong X; Zhu X; Wang C; Zhou Y; Yan Y; Zhan S; Zhu H; Han S; Cheng Y
    Front Pharmacol; 2022; 13():883407. PubMed ID: 35800448
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse events to Houttuynia injection: A systematic review.
    Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
    J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese Children.
    Tan L; Li M; Lin Y
    Evid Based Complement Alternat Med; 2019; 2019():8310368. PubMed ID: 31341500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial.
    Zhang XY; Lv L; Zhou YL; Xie LD; Xu Q; Zou XF; Ding Y; Tian J; Fan JL; Fan HW; Yang YX; Ye XQ
    Phytother Res; 2021 Aug; 35(8):4401-4410. PubMed ID: 33979464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions of Shuanghuanglian injection: a systematic review of public literatures.
    Wang L; Cheng L; Yuan Q; Cui X; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 Feb; 3(1):18-26. PubMed ID: 21349036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xiyanping injection combined with acitretin for psoriasis vulgaris: A systematic review and meta-analysis.
    Wu MN; Zhou LJ; Zhou DM
    Front Pharmacol; 2022; 13():971715. PubMed ID: 36147319
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse drug reactions linked to Ciwujia injection: a systematic review of 521 cases.
    Hu J; Shang H; Li J; Zhang L; Zhang J; Zheng W; Li T; Zhang B; Li Y
    J Evid Based Med; 2010 Feb; 3(1):37-43. PubMed ID: 21349038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions of Shenmai injection: a systematic review.
    Zhang L; Hu J; Xiao L; Zhang Y; Zhao W; Zheng W; Shang H
    J Evid Based Med; 2010 Aug; 3(3):177-82. PubMed ID: 21349063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Effects of Andrographolide Derivative Medications Compared to the Safe use of Herbal Preparations of
    Shang YX; Shen C; Stub T; Zhu SJ; Qiao SY; Li YQ; Wang RT; Li J; Liu JP
    Front Pharmacol; 2022; 13():773282. PubMed ID: 35153776
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of adverse drug reactions in pediatric patients.
    Priyadharsini R; Surendiran A; Adithan C; Sreenivasan S; Sahoo FK
    J Pharmacol Pharmacother; 2011 Oct; 2(4):277-80. PubMed ID: 22025857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of Chinese herbal injections for the treatment of community-acquired pneumonia: A Bayesian network meta-analysis of randomized controlled trials.
    Huang X; Duan X; Zhu Y; Wang K; Wu J; Tian X
    Phytomedicine; 2019 Oct; 63():153009. PubMed ID: 31301540
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.